Trifluorothymidine Resistance Is Associated with Decreased Thymidine Kinase and Equilibrative Nucleoside Transporter Expression or Increased Secretory Phospholipase A2
Olaf H. Temmink(Amsterdam UMC Location Vrije Universiteit Amsterdam), Godefridus J. Peters(Gdańsk Medical University), Richard J. Honeywell(Amsterdam University Medical Centers), Kees Smid(Vrije Universiteit Amsterdam), Irene V. Bijnsdorp(Amsterdam UMC Location Vrije Universiteit Amsterdam), Nienke Losekoot(Amsterdam UMC Location Vrije Universiteit Amsterdam), Auke D. Adema(Taiho Pharmaceutical (Japan)), Paul P. Eijk, Bauke Ylstra(Amsterdam University Medical Centers), Masakazu Fukushima(Taiho Pharmaceutical (Japan)), Henk‐Jan Prins(University Medical Center Utrecht)
Cited by 30
Related Papers
Fluorouracil: biochemistry and pharmacology.
|Journal of Clinical Oncology|1988|834
Nontemplated Nucleotide Additions Distinguish the Small RNA Composition in Cells from Exosomes
|Cell Reports|2014|592
Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing
|European Journal of Cancer and Clinical Oncology|1991|460
Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism
|Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease|2002|430